When a clinician asks an answer engine about a therapy, the model returns one fluent paragraph, not ten blue links. That single answer is now a primary information surface. A Doximity survey of 3,151 U.S. physicians found that 54% already use AI in clinical practice, with literature search the most common use case at 35% in January 2026, up from 22% in April 2025 (Doximity). Meanwhile Pew Research found that when Google shows an AI summary, users click a source link inside that summary in just 1% of visits to pages with such a summary (Pew Research Center). The answer is the destination. So you need to measure the answer.
Traditional web analytics cannot see inside a generated answer. You need a different instrument and a different scoreboard. Below are six core KPIs that turn "what is the AI telling people about our brand" into numbers a marketing, medical, or regulatory leader can act on. Each is defined plainly so you can lift it straight into a dashboard, a steering-committee slide, or your own internal AEO program. Throughout, the worked example uses a fictional brand, Varigel, and the five canonical engines that matter in pharma: ChatGPT, Gemini, Perplexity, Google AI Overviews, and Claude.
1. Share of Answer (SoA)
Share of Answer is the percentage of relevant AI answers that mention your brand at all. You define a fixed set of questions an HCP or patient would actually ask, you run them across the engines, and you count the answers that name your product.
The web-analytics world already converged on this shape under the label "AI share of voice," defined as how visible your brand is in AI responses based on how often it is mentioned and how high it appears relative to competitors, tracked across the engines buyers use such as ChatGPT, Google AI Mode, and Perplexity (Semrush). In pharma the stakes are higher because the alternative to your brand showing up is a competitor, a generic, or an out-of-date guideline showing up instead.
SoA is the headline visibility number. A low SoA means the models do not consider you part of the conversation for that disease area. It says nothing yet about whether the mention is accurate or safe, which is why it is only the first of six.
2. Ecosystem Share of Answer (Ecosystem SoA)
Ecosystem SoA is Share of Answer measured relative to the full competitive set, not in isolation. In the share-of-voice framing, the figures for all brands in a category add up to 100%, so if your brand accounts for 15 of every 100 brand mentions across the answers to your question set, your Ecosystem SoA is 15% (Semrush).
This is the KPI that turns "we appear sometimes" into "we own X% of the AI conversation versus these named competitors." It is also where engine-to-engine variability becomes visible and important. Independent testing of the same query across major AI engines routinely produces little overlap in which brands and sources surface, with no single recommendation appearing across all of them (SEO.com). You can be the dominant voice on one engine and nearly absent on another for the identical question. Ecosystem SoA, broken out per engine, exposes exactly where you are losing the category and to whom.
3. Precision of Answer (PoA)
Precision of Answer measures whether what the model says about you is correct. It is the share of brand mentions that are factually accurate and consistent with the approved label, as opposed to confident-sounding but wrong.
This KPI exists because answer engines fabricate. A comparative analysis in the Journal of Medical Internet Research found hallucinated references in 28.6% of GPT-4 outputs and 39.6% of GPT-3.5 outputs when generating citations for systematic reviews, with a far worse rate of 91.4% for the Bard model tested (JMIR). A model can name your drug, attach a plausible mechanism, and cite a study that does not exist. Precision of Answer scores each mention against ground truth: the indication, the population, the dosing, the cited evidence. A high SoA with a low PoA is not a win. It means the AI is talking about you and getting it wrong, at scale, with no human in the loop.
4. Risk of Answer (RoA), where higher is worse
Risk of Answer is the one KPI where you want the number to fall. It quantifies how often AI answers about your brand contain a compliance or safety problem: an off-label use stated as fact, a benefit overstated, a material risk omitted, or fair balance broken.
The standard here is not invented. FDA states that prescription drug promotion must not be false or misleading, must present a balance between efficacy and risk information, and must reveal material facts, and it lists overstating benefits, downplaying risk, and failing to present a fair balance as common drug-promotion problems (FDA OPDP, Bad Ad Program). An AI answer that lists Varigel's efficacy and skips its contraindications would fail that standard if a brand had written it. You did not write it, but your audience cannot tell the difference, and a regulator reviewing the landscape may not draw the line where you would hope. Risk of Answer flags those answers so medical and regulatory teams see them before anyone else does. Track it as a count and a rate, set a threshold, and treat a spike as an incident, not a metric.
5. Claim Uptake
Claim Uptake measures how many of your approved, on-label claims actually appear in AI answers, and in what proportion versus claims you never made. It is the bridge between the content you have cleared and the content the models are echoing.
This is the difference between absence and distortion. Low Claim Uptake means your carefully approved messaging is invisible: the models are filling the vacuum with whatever they scraped, which is also what drives Risk of Answer up. High Claim Uptake means the language your medical and regulatory teams signed off on is the language the AI is reusing. Because identical prompts can return different sources and framings on different days and different engines (SEO.com), Claim Uptake is best read as a trend per claim per engine, not a one-time snapshot.
6. Top References
Top References is the ranked list of the sources the engines actually cite when they answer questions about your brand and category. It answers the practical question: which pages, journals, registries, and third-party sites are feeding the machine.
This matters because citation behavior is often disconnected from classic search rankings. One analysis cited an Ahrefs study of 15,000 long-tail queries that found only 12% of the links cited by ChatGPT, Gemini, and Copilot overlapped with Google's top 10 results for the same prompts, and that 4 out of 5 citations pointed to pages with no ranking presence at all for the target query (iPullRank). You cannot assume the source ranking number one on Google is the source the model trusts. Top References tells you which inputs to prioritize, correct, or earn. If a stale forum thread or a competitor-funded review outranks your label and your peer-reviewed data as a model citation, that is your highest-leverage fix.
Worked example: Varigel across five engines
Suppose Varigel is a fictional therapy in a crowded category. You assemble 60 HCP-style questions and run them across all five engines weekly. The picture that emerges:
- Share of Answer: Varigel is named in 42% of relevant answers. Reasonable presence.
- Ecosystem SoA: but only 12% of all brand mentions are Varigel, versus 31% for the category leader. You are present, not dominant, and you are weakest on Gemini.
- Precision of Answer: of the answers that mention Varigel, 84% are accurate. The other 16% misstate the indication or attach a study that does not support the claim.
- Risk of Answer: three answers this week described an unapproved use as established, and two omitted a boxed-warning-level risk. Higher than zero, so this is the queue medical reviews first.
- Claim Uptake: only 2 of your 9 approved claims show up with any regularity. The models are paraphrasing third parties instead.
- Top References: the engines lean on a patient forum and an outdated guideline more than on your label or your published trial data.
None of those six numbers alone tells the story. Together they say: Varigel is visible but losing the category, is described accurately most of the time but dangerously sometimes, and is being characterized by sources you do not control. That is a plan, not a panic.
Where this leaves you
The six KPIs are useful precisely because they separate four different failure modes that look identical from the outside. Invisibility is a Share of Answer and Ecosystem SoA problem. Inaccuracy is a Precision of Answer problem. Non-compliance is a Risk of Answer problem. And losing the narrative to the wrong inputs is a Claim Uptake and Top References problem. Each has a different owner and a different fix.
Juncture's Answer Monitor is built to report exactly these six Core KPIs across ChatGPT, Gemini, Perplexity, Google AI Overviews, and Claude, with off-label detection, drift tracking over time, and an AI Answer Readiness site diagnostic underneath the headline numbers. Its advantage is the inside-to-outside join: because Juncture also holds your approved claims library in Content Intelligence and your label-grounded rules in Pre-Check, it can score what the AI says against what you actually cleared, so Claim Uptake and Risk of Answer are measured against ground truth rather than guessed. Measuring the answer is the new table stakes. See /answer-monitor for how the six KPIs come together in one view.
Sources
- Doximity 2026 State of AI in Medicine Report
- Pew Research Center: Google users are less likely to click on links when an AI summary appears in the results (2025)
- Semrush: How to Measure AI Share of Voice Using Semrush
- SEO.com: Do AI Search Engines Respond the Same to the Same Query?
- Journal of Medical Internet Research / PMC: Hallucination Rates and Reference Accuracy of ChatGPT and Bard for Systematic Reviews
- FDA Office of Prescription Drug Promotion: The Bad Ad Program (oversight of prescription drug promotion; fair balance of risk and benefit)
- iPullRank: AI Search and the Probability of Citation